vs
CITIZENS FINANCIAL SERVICES INC（CZFS）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
RHYTHM PHARMACEUTICALS, INC.的季度营收约是CITIZENS FINANCIAL SERVICES INC的2.0倍（$60.1M vs $29.6M），CITIZENS FINANCIAL SERVICES INC净利率更高（35.4% vs -92.6%，领先128.0%），RHYTHM PHARMACEUTICALS, INC.同比增速更快（83.8% vs 13.0%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（43.8% vs 6.9%）
公民金融集团是一家美国银行控股公司，总部位于罗得岛州普罗维登斯。集团旗下拥有公民银行（Citizens Bank, N.A.），业务覆盖美国康涅狄格、特拉华、佛罗里达等十余个州及华盛顿哥伦比亚特区。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
CZFS vs RYTM — 直观对比
营收规模更大
RYTM
是对方的2.0倍
$29.6M
营收增速更快
RYTM
高出70.8%
13.0%
净利率更高
CZFS
高出128.0%
-92.6%
两年增速更快
RYTM
近两年复合增速
6.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $29.6M | $60.1M |
| 净利润 | $10.5M | $-55.6M |
| 毛利率 | — | 88.1% |
| 营业利润率 | 44.2% | -87.1% |
| 净利率 | 35.4% | -92.6% |
| 营收同比 | 13.0% | 83.8% |
| 净利润同比 | 31.3% | — |
| 每股收益（稀释后） | $2.17 | $-0.83 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CZFSRYTM
| Q1 26 | — | $60.1M | ||
| Q4 25 | $29.6M | $57.3M | ||
| Q3 25 | $29.0M | $51.3M | ||
| Q2 25 | $27.3M | $48.5M | ||
| Q1 25 | $26.4M | $32.7M | ||
| Q4 24 | $26.2M | $41.8M | ||
| Q3 24 | $25.1M | $33.3M | ||
| Q2 24 | $24.6M | $29.1M |
净利润CZFSRYTM
| Q1 26 | — | $-55.6M | ||
| Q4 25 | $10.5M | $-47.5M | ||
| Q3 25 | $10.0M | $-52.9M | ||
| Q2 25 | $8.5M | $-46.6M | ||
| Q1 25 | $7.6M | $-49.5M | ||
| Q4 24 | $8.0M | $-43.3M | ||
| Q3 24 | $7.5M | $-43.6M | ||
| Q2 24 | $5.3M | $-32.3M |
毛利率CZFSRYTM
| Q1 26 | — | 88.1% | ||
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% |
营业利润率CZFSRYTM
| Q1 26 | — | -87.1% | ||
| Q4 25 | 44.2% | -82.2% | ||
| Q3 25 | 42.6% | -102.6% | ||
| Q2 25 | 38.1% | -93.4% | ||
| Q1 25 | 35.5% | -143.7% | ||
| Q4 24 | 37.2% | -98.6% | ||
| Q3 24 | 36.9% | -132.0% | ||
| Q2 24 | 25.9% | -139.2% |
净利率CZFSRYTM
| Q1 26 | — | -92.6% | ||
| Q4 25 | 35.4% | -83.0% | ||
| Q3 25 | 34.5% | -103.1% | ||
| Q2 25 | 31.0% | -96.1% | ||
| Q1 25 | 28.8% | -151.4% | ||
| Q4 24 | 30.5% | -103.6% | ||
| Q3 24 | 30.0% | -131.2% | ||
| Q2 24 | 21.4% | -110.9% |
每股收益（稀释后）CZFSRYTM
| Q1 26 | — | $-0.83 | ||
| Q4 25 | $2.17 | $-0.73 | ||
| Q3 25 | $2.09 | $-0.82 | ||
| Q2 25 | $1.76 | $-0.75 | ||
| Q1 25 | $1.60 | $-0.81 | ||
| Q4 24 | $1.64 | $-0.71 | ||
| Q3 24 | $1.57 | $-0.73 | ||
| Q2 24 | $1.10 | $-0.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $34.3M | $340.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $338.1M | $122.9M |
| 总资产 | $3.1B | $442.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CZFSRYTM
| Q1 26 | — | $340.6M | ||
| Q4 25 | $34.3M | $388.9M | ||
| Q3 25 | $31.1M | $416.1M | ||
| Q2 25 | $49.5M | $291.0M | ||
| Q1 25 | $36.8M | $314.5M | ||
| Q4 24 | $42.2M | $320.6M | ||
| Q3 24 | $36.8M | $298.4M | ||
| Q2 24 | $38.4M | $319.1M |
股东权益CZFSRYTM
| Q1 26 | — | $122.9M | ||
| Q4 25 | $338.1M | $139.1M | ||
| Q3 25 | $327.7M | $148.8M | ||
| Q2 25 | $313.7M | $-11.9M | ||
| Q1 25 | $308.3M | $18.9M | ||
| Q4 24 | $299.7M | $21.7M | ||
| Q3 24 | $298.7M | $11.2M | ||
| Q2 24 | $286.5M | $39.3M |
总资产CZFSRYTM
| Q1 26 | — | $442.3M | ||
| Q4 25 | $3.1B | $480.2M | ||
| Q3 25 | $3.1B | $506.9M | ||
| Q2 25 | $3.0B | $372.7M | ||
| Q1 25 | $3.0B | $386.7M | ||
| Q4 24 | $3.0B | $392.3M | ||
| Q3 24 | $3.0B | $363.6M | ||
| Q2 24 | $2.9B | $381.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $36.5M | — |
| 自由现金流经营现金流 - 资本支出 | $35.2M | — |
| 自由现金流率自由现金流/营收 | 119.0% | — |
| 资本支出强度资本支出/营收 | 4.4% | — |
| 现金转化率经营现金流/净利润 | 3.49× | — |
| 过去12个月自由现金流最近4个季度 | $53.8M | — |
8季度趋势，按日历期对齐
经营现金流CZFSRYTM
| Q1 26 | — | — | ||
| Q4 25 | $36.5M | $-25.4M | ||
| Q3 25 | $2.9M | $-26.6M | ||
| Q2 25 | $6.0M | $-23.3M | ||
| Q1 25 | $10.9M | $-40.4M | ||
| Q4 24 | $33.2M | $-18.8M | ||
| Q3 24 | $6.2M | $-25.2M | ||
| Q2 24 | $3.0M | $-29.1M |
自由现金流CZFSRYTM
| Q1 26 | — | — | ||
| Q4 25 | $35.2M | — | ||
| Q3 25 | $2.7M | — | ||
| Q2 25 | $5.5M | — | ||
| Q1 25 | $10.4M | — | ||
| Q4 24 | $31.9M | — | ||
| Q3 24 | $5.6M | — | ||
| Q2 24 | $2.9M | — |
自由现金流率CZFSRYTM
| Q1 26 | — | — | ||
| Q4 25 | 119.0% | — | ||
| Q3 25 | 9.4% | — | ||
| Q2 25 | 20.1% | — | ||
| Q1 25 | 39.2% | — | ||
| Q4 24 | 121.6% | — | ||
| Q3 24 | 22.3% | — | ||
| Q2 24 | 11.8% | — |
资本支出强度CZFSRYTM
| Q1 26 | — | — | ||
| Q4 25 | 4.4% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 0.5% | — |
现金转化率CZFSRYTM
| Q1 26 | — | — | ||
| Q4 25 | 3.49× | — | ||
| Q3 25 | 0.29× | — | ||
| Q2 25 | 0.71× | — | ||
| Q1 25 | 1.44× | — | ||
| Q4 24 | 4.16× | — | ||
| Q3 24 | 0.83× | — | ||
| Q2 24 | 0.57× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
